Latest Masimo Corporation Stories
IRVINE, Calif., July 26, 2012 /PRNewswire/ -- According to a new study in the July 2012 print edition of Anesthesiology, blood transfusion, the most common procedure performed in U.S. hospitals(1), has wide variation in frequency by surgical procedure and physician as well as wide variation in the hemoglobin trigger used to help decide whether to transfuse.(2) The study also showed a significant number of transfusion decisions are made without laboratory hemoglobin measurements. The...
IRVINE, Calif., July 23, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today that MWI Veterinary Supply, Inc. (NASDAQ: MWIV), one of the largest national distributors of medical supplies and equipment to veterinarians, will for the first time distribute Masimo products. Masimo's Radical-7(®) Pulse CO-Oximeter with upgradable rainbow(®) technology and Masimo's handheld Rad-5(®) and portable Rad-8(®) with SET Measure-through Motion and Low Perfusion pulse oximetry will...
IRVINE, Calif., July 18, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today that it will release second quarter financial results for the period ended June 30, 2012, after the market closes on August 1, 2012. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Mark P. de Raad, Executive Vice President and Chief Financial Officer. A live webcast of the conference call...
IRVINE, Calif., July 9, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today a new study in Respiratory Physiology & Neurobiology shows that noninvasive carboxyhemoglobin (SpCO®) and methemoglobin (SpMet®) measurements with Masimo rainbow® Pulse CO-Oximetry(TM) are accurate and conclude they can be used as an effective first screening test with emergency room patients suspected of suffering carbon monoxide (CO) poisoning.(1) CO poisoning is a major cause of morbidity and...
IRVINE, Calif., July 3, 2012 /PRNewswire/ -- The U.S. Department of Defense Military Health System has selected the Masimo Rad-57(TM) Handheld Pulse CO-Oximeter as the military's standardized handheld pulse oximeter for use worldwide, Masimo (NASDAQ: MASI) announced today. This agreement is available to all designated Medical Treatment Facilities and Operational Field Units across the Department of Defense's global healthcare system, from first responders to definitive care. The...
IRVINE, Calif., July 2, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today that PSS World Medical, Inc., (NASDAQ: PSSI) a leading national distributor of medical supplies and equipment to office-based physicians, will distribute the new Pronto-7(TM) - a palm-sized handheld device designed for quick and easy noninvasive spot-checking of total hemoglobin (SpHb®), SpO2, pulse rate, and perfusion index. (Photo: http://photos.prnewswire.com/prnh/20110808/LA46231) Pronto-7...
IRVINE, Calif., June 21, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today a new study in The American Journal of Emergency Medicine demonstrates for the first time that compared to invasive carboxyhemoglobin (COHb) measurement with laboratory CO-oximetry, noninvasive carboxyhemoglobin (SpCO®) measurement with Masimo rainbow® Pulse CO-Oximetry(TM) leads to more rapid diagnosis of carbon monoxide (CO) poisoning and a shorter time to the initiation of treatment with...
OTTAWA, Ontario, June 19, 2012 /PRNewswire/ -- Kinaxis®, provider of RapidResponse®, a cloud-based solution at the heart of planning and response management for value chain operations, today announced that Masimo Corporation, a leading medical device provider, has deployed Kinaxis RapidResponse as its core planning and analytics engine. (Logo: http://photos.prnewswire.com/prnh/20120208/CG49456LOGO-b) Masimo develops and manufactures noninvasive patient monitoring technologies....
IRVINE, Calif., June 18, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today that a follow-up analysis appearing in the Spring-Summer 2012 issue of the Anesthesia Patient Safety Foundation newsletter demonstrated that implementing Masimo SET Measure-through Motion and Low Perfusion pulse oximetry and the Masimo Patient SafetyNet((TM)) remote monitoring and clinician notification system in all post-surgical, general floor units at Dartmouth Hitchcock Medical Center resulted...
IRVINE, Calif., June 13, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today that Henry Schein Medical, the Medical business of Henry Schein, Inc., (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based practitioners, will distribute the new Pronto-7(TM) - a palm-sized handheld device designed for quick and easy noninvasive spot-checking of total hemoglobin (SpHb®), SpO2, pulse rate, and perfusion index. (Photo:...
